References

kpccz

Комплексные проблемы сердечно-сосудистых заболеваний

Complex Issues of Cardiovascular Diseases

2306-12782587-9537

Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”

10.17802/2306-1278-2016-2-46-50

kpccz-189

Research Article

ИННОВАЦИОННЫЕ СТРАТЕГИИ В СЕРДЕЧНО-СОСУДИСТОЙ ХИРУРГИИ

INNOVATIVE STRATEGIES IN CARDIOVASCULAR SURGERY

Мини -инвазивная гибридная реваскуляризация миокарда при многососудистом поражении коронарного русла . Современное состояние вопроса

Hybrid minimally invasive myocardial revascularization in multivessel coronary disease . Current status of the issue

Ганюков

В. И.

Ganyukov

V. I.

Тарасов

Р. С.

Tarasov

R. S.

Адрес: 650002, г. Кемерово, Сосновый бульвар, 6 Тел. 8 (3842) 64-18-06

Address: 6, Sosnoviy blvd., Kemerovo, 650002, Russian Federation Tel. +7 (3842) 64-18-06

tarars@kemcardio.ru

Шилов

А. А.

Shilov

A. A.

Кочергин

Н. А.

Kochergin

N. A.

Барбараш

Л. С.

Barbarash

L. S.

Федеральное государственное бюджетное научное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», лаборатория интервенционных методов диагностики и лечения атеросклероза. Кемерово, РоссияРоссияFederal State Budgetary Scientific Institution Research Institute for Complex Issues of Cardiovascular Diseases, Laboratory of Interventional Cardiology, Laboratory of Reconstructive Surgery. Kemerovo, RussiaRussian Federation

2016

27062016

024650

2016

Ганюков В.И., Тарасов Р.С., Шилов А.А., Кочергин Н.А., Барбараш Л.С.

Ganyukov V.I., Tarasov R.S., Shilov A.A., Kochergin N.A., Barbarash L.S.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.nii-kpssz.com/jour/article/view/189

В данной статье приводится обзор литературы по проблеме малоинвазивной гибридной реваскуляризации миокарда у пациентов со стабильной ИБС при многососудистом поражении коронарного русла. Анонсируется дизайн собственного рандомизированного исследования HREVS (Hybrid REvascularization Vs Surgery), сравнивающего результаты реваскуляризации миокарда с применением трех стратегий: 1) гибридной реваскуляризации (шунтирование передней нисходящей артерии из мини-доступа на работающем сердце и стентирование других коронарных артерий с использованием стентов с лекарственным покрытием); 2) стандартного коронарного шунтирования в условиях искусственного кровообращения; 3) многососудистого стентирования коронарных артерий с применением стентов с лекарственным покрытием.

This article provides an overview of the literature on the issue of minimally invasive hybrid revascularization in patients with stable multivessel coronary artery disease. It is announced design of randomized study HREVS (Hybrid REvascularization Vs Surgery), to compare the results of myocardial revascularization using three strategies: 1) hybrid revascularization minimally invasive on pump coronary artery bypass surgery LIMA to LAD (MID CAB) and stenting of other coronary arteries using drug-eluting stents); 2) coronary artery bypass grafting with cardiopulmonary bypass; 3) multivessel coronary stenting with drug-eluting stents.

гибридная реваскуляризация миокардачрескожное коронарное вмешательствокоронарное шунтирование

hybrid revascularizationpercutaneous coronary interventioncoronary artery bypass grafting

References1

Барбараш Л. С., Ганюков В. И. Организация и тактика проведения чрескожного коронарного вмешательства при инфаркте миокарда с подъемом сегмента ST. Кемерово; 2012: 230 с. Barbarash L. S., Ganyukov V. I. Organisation and tactic of percutaneous coronary intervention in patients with ST segment elevation myocardial infarction. Kemerovo; 2012: 230. [In Russ.].

Тарасов Р. С. Эндоваскулярная реваскуляризация у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении коронарного русла. Автореф. дис. … д-ра мед. наук. М; 2015. Tarasov R. S. Endovascular revascularization in patients with ST-segment elevation myocardial infarction [dissertation]. Moskow; 2015. [In Russ.].

Синьков М. А. Эффективность первичного чрескожного коронарного вмешательства у больных инфарктом миокарда с подъемом сегмента ST и сопутствующим мультифокальным атеросклерозом. Автореф. дис. … канд. мед. наук. Новосибирск; 2011. Sinkov M. A. Efficiency of primary PCI in patients with ST-segment elevation myocardial infarction and multivascular disease [dissertation]. Novosibirsk; 2011. [In Russ.].

Азаров А. А. Факторы, влияющие на результаты коронарного стентирования у пациентов с инфарктом миокарда и сахарным диабетом 2 типа. Автореф. дис. … канд. мед. наук. Кемерово; 2011. Azarov A. A. Factors influence to the results of coronary stenting in patients with ST-segment elevation myocardial infarction and diabetes mellitus [dissertation]. Kemerovo; 2011. [In Russ.].

Кашталап В. В. Клиническая и прогностическая значимость молекулярно-генетических маркеров формирования и прогрессирования мультифокального атеросклероза у больных инфарктом миокарда с подъемом сегмента ST. Автореф. дис. … д-ра мед. наук. Кемерово; 2015. Kashtalap V. V. Clinical and prognostic significance of molecular and genetic markers of formation and progression of multifocal atherosclerosis in ST-segment elevation myocardial infarction patients [dissertation]. Kemerovo; 2015. [In Russ.].

Шафранская К. С. Прогнозирование отдаленных результатов коронарного шунтирования у пациентов с мультифокальным атеросклерозом. Автореф. дис. … канд. мед. наук. Кемерово; 2011. Shafranskaja K. S. Prediction of long-term outcomes of coronary artery bypass grafting in patients with multifocal atherosclerosis [dissertation]. Kemerovo; 2011. [In Russ.].

Херасков В. Ю. Инновационные подходы управления риском неблагоприятного исхода острого коронарного синдрома, осложненного кардиогенным шоком. автореф. дис. … канд. мед. наук. Кемерово; 2015. Heraskov V. Yu. Innovative approaches of management of the risk of adverse outcome in acute coronary syndrome complicated by cardiogenic shock [dissertation]. Kemerovo; 2015. [In Russ.].

Иванов С. В., Сумин А. Н., Казачек Я. В., Филипьев Д. Е., Гусев С. М., Малышенко Е. С., Барбараш Л. С. Пути оптимизации результатов реваскуляризации у пациентов с мультифокальным атеросклерозом. Комплексные проблемы сердечно-сосудистых заболеваний. 2013; 3: 26–35. DOI: 10.17802/2306-1278-2013-3-26-35. Ivanov S. V., Sumin A. N., Kazachek Ya. V., Philipiev D. E., Gusev S. M., Malyshenko E. S., Barbarash L. S. Options for revascularization outcomes optimization in patients with polyvascular disease. Complex Issues of Cardiovascular Diseases. 2013; 3: 26–35. DOI: 10.17802/2306-1278-2013-3-26-35. [In Russ.].

Jeremias A., Kaul S., Rosengart T. K. et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am. J. Med. 2009; 122: 152–161.

Serruys P. W., Morice M. C., Kappetein A. P. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360: 961–972.

Farkouh M. E., Domanski M., Sleeper L. A. et al. Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 2012; 367: 2375–2384.

Tatoulis J., Buxton B. F., Fuller J. A. Patencies of 2127 arterial to coronary conduits over 15 years. Ann. Thorac. Surg. 2004; 77: 93–101.

Mehta R. H., Honeycutt E., Shaw L. K. et al. Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting. Am. J. Cardiol. 2007; 100: 1538–1542.

Cameron A., Davis K. B., Green G., Schaff H. V. Coronary Bypass Surgery with Internal-Thoracic-Artery Grafts – Effects on Survival over a 15-Year Period. NEJM. 1996; 334: 216–220.

Hayward P. A., Buxton B. F. Contemporary сoronary graft patency: 5-year observational data from a randomized trial of conduits. Ann. Thorac. Surg. 2007; 84: 795–799.

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N. Engl. J. Med. 1996; 335: 217–225.

CASS Principal Investigators and their associates. Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Survival data. Circulation. 1983; 68: 939–950.

2011 ACCF/AHA/SCAI Guideline for Coronary Artery Bypass Graft Surgery. J. Am. Coll. Cardiol. 2011; 1. DOI: 10.1016/j. jacc.2011.08.009.

Girasis C., Garg S., Räber L. et al. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur. Heart. J. 2011; 32 (24): 3115–3127.

Benetti F. J., Ballester C., Sani G. et al. Video assisted coronary bypass surgery. J. Cardiac. Surg. 1995; 10: 620–625.

Calafiore A. M., Gianmarco G. D., Teodori G. et al. Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann. Thorac. Surg. 1996; 61: 1658–1665.

Puskas J., Cheng D., Knight J. et al. Off-pump versus conventional coronary artery bypass grafting: a meta-analysis and consensus statement from the 2004 ISMICS consensus conference. Innovations. 2005; 1: 3–27.

Kon Z. N., Brown E. N., Tran R. et al. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J. Thorac. Cardiovasc. Surg. 2008; 135: 367–375.

DeRose J. J. Current state of integrated “hybrid” coronary revascularization. Semin. Thorac. Cardiovasc. Surg. 2009; 21: 229–236.

Deкose J. J., Balaram S. K., Ro C. et al. Mid-term results and patient perceptions of robotically assisted coronary artery bypass grafting. Int. Cardiovasc. Thorac. Surg. 2005; 4: 406–411.

Meharwal Z. S., Mishra Y. K., Kohli V., Bapna R., Singh S., Trehan N. Off-pump multivessel coronary artery surgery in high-risk patients. Ann. Thorac. Surg. 2002; 74 (4): 1353–1357.

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. J. Am. Coll. Cardiol. 2011; 7. DOI: 10.1016/j. jacc.2011.08.007.

Sawhney N., Moses J. W., Leon M. B. et al. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation. 2004; 110: 374–379.

Weisz G., Leon M. B., Holmes Jr. D. R. et al. Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. J. Am. Coll. Cardiol. 2006; 47: 1350– 1355.

Stettler C., Wandel S., Allemann S., Kastrati A. et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007; 370: 937–948.

Ashby D. T., Dangas G., Mehran R. et al. Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries. Am. J. Cardiol. 2002; 89: 1162–1166.

Kappetein A. P., Feldman T. E., Mack M. J. et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur. Heart. J. 2011; 32: 2125–2134.

Hlatky M. A., Boothroyd D. B., Bravata D. M. et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009; 373: 1190–1197.

Mohr F., Redwood S., Venn G. et al. TCT-43 Final fiveyear follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease. J. Am. Coll. Cardiology. 2012; 60: 17.

Repossini A., Moriggia S., Cianci V. et al. The LAST operation is safe and effective: MIDCABG clinical and angiographic evaluation. Ann. Thorac. Surg. 2000; 70 (1): 74–78.

Angelini G. D., Wilde P., Salerno T. A., Bosco G., Calafiore A. M. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularization. Lancet. 1996; 347: 757–758.

Byrne J. G., Leacche M., Vaughan D. E., Zhao D. X. Hybrid cardiovascular procedures. J. Am. Coll. Cardiol. Intv. 2008; 32: 459–468.

Vassiliades T. A. Jr., Reddy V. S., Puskas J. D. et al. Long-term results of the endoscopic atraumatic coronary artery bypass. Ann. Thorac. Surg. 2007; 83: 979–985.

Hayward P. A., Buxton B. F. Contemporary coronary graft patency: 5-year observational data from a randomized trial of conduits. Ann. Thorac. Surg. 2007; 84: 795–799.

McGinn J. T. Jr., Usman S., Lapierre H. et al. Minimally Invasive Coronary Artery Bypass Grafting: Dual-Center Experience in 450 Consecutive Patients Circulation. 2009; 120: 78–84.

Kim J. H., Newby L. K., Clare R. M. et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. Am. Heart. J. 2008; 156: 886–892.

Zhao D. X., Leacche M., Jorge M. Routine Intraoperative Completion Angiography After Coronary Artery Bypass Grafting and 1-Stop Hybrid Revascularization: Results From a Fully Integrated Hybrid Catheterization Laboratory/Operating Room. J. Am. Coll. Cardiology. 2009; 53 (3): 232–241.

Hu S. S., Xiong H., Zheng Z. et al. Midterm outcomes of simultaneous hybrid coronary artery revascularization for left main coronary artery disease. Heart. Surg. Forum. 2012; 15: 18–22.

Kiaii B., McClure R. S., Stewart P. et al. Simultaneous integrated coronary artery revascularization with long-term angiographic follow-up. J. Thorac. Cardiovasc. Surg. 2008; 136: 702–708.

Reicher B., Poston R. S., Mehra M. R. et al. Simultaneous “hybrid” percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am. Heart. J. 2008; 155: 661–667.

Damman P., Woudstra P., Kuijt W. J. et al. P2Y12 platelet inhibition in clinical practice. J. Thromb. Thrombolysis. 2012; 33: 143–153.

Bonatti J., Schachner T., Bernecker O. et al. Robotic totally endoscopic coronary artery bypass: program development and learning curve issues. J. Thorac. Cardiovasc. Surg. 2004; 127: 504–510.

Aubin H., Akhyari P., Lichtenberg A. et al. Additional right-sided upper «Half-Mini-Thoracotomy» for aortocoronary bypass grafting during minimally invasive multivessel revascularization. J. Cardiothorac. Surg. 2015; 10: 130. DOI: 10.1186/s13019-015-0334-6.

Harskamp R. E. Current state and future direction of hybrid coronary revascularization. Curr. Opin. Cardiol. 2015; 6: 643–649. DOI: 10.1097/HCO.0000000000000223.

Zhu P., Zhou P., Sun Y. et al. Hybrid coronary revascularization versus coronary artery bypass grafting for multivesselcoronary artery disease: systematic review and metaanalysis. J. Cardiothorac. Surg. 2015; 10: 63. DOI: 10.1186/ s13019-015-0262-5.

2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2014; 35: 2541–2619.

The authors declare that there are no conflicts of interest present.